ICON shares are trading higher after the company announced a multi-year collaboration with Anthropic to bring Claude’s AI capabilities across the clinical trial lifecycle.

ICON Plc

ICON Plc

ICLR

0.00

ICON shares are trading higher after the company announced a multi-year collaboration with Anthropic to bring Claude’s AI capabilities across the clinical trial lifecycle.